Volatility can lower the cost of entry into businesses that throw off real cash, even as investors recognize that a low share ...

The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

Final results from the CNS-101 study, published in Frontiers in Digital Health, show that the NeuLogiq Platform can be used ...

CorMedix is shifting from a single-product launch story as DefenCath drives revenue and Rezzayo adds long-term potential ...

The company said the independent safety board reviewing the study saw a clear trend favoring the Annamycin combination, though there was no statistical significance. ・Full data from the first part of ...

Pharmaceutical companies are on an M&A spree that could break records this year as they look for novel drug and clinical-stage candidates to bolster the development pipeline.

The FAST study, officially titled “Evaluation of Function And Satisfaction of UbrogepanT-treated Migraine Patients in Canada,” looks at how well adults function and how satisfied they feel after using ...

Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing inhaled therapies for serious respiratory diseases, today announced the appointments of Daniel G. Welch as Chairman of its ...

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly effective at preventing infectious diseases, including COVID-19. The new review ...

U.S. District Judge M. Casey Rodgers, in the Northern District of Florida, postponed her expert ruling this month due to a ...

The FDA approved Zoryve cream 0.3% for the treatment of plaque psoriasis in children as young as 2 years, Arcutis announced ...